SUSTAINED EFFICACY, SAFETY, AND IMMUNOLOGICAL IMPROVEMENT OVER 7 YEARS WITH FOSTEMSAVIR-BASED REGIMENS IN INDIVIDUALS WITH HIV-1 AND LIMITED TREATMENT OPTIONS IN LATIN AMERICA

Authors
Category Primary study
Conference24th Brazilian Congress of Infectious Diseases 2025
Year 2026
This article has no abstract
Epistemonikos ID: 4fd47a366195f782d44e993aa762c71c5c1dc1f3
First added on: Jun 20, 2026